Tertiary lymphoid structures correlate with enhancement of antitumor immunity in esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Tertiary lymphoid structures correlate with enhancement of antitumor immunity in esophageal squamous cell carcinoma

Published:2023-08-21 Issue:8 Volume:129 Page:1314-1326
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Nakamura Shoichi,Ohuchida Kenoki^ORCID,Hayashi Masataka,Katayama Naoki,Tsutsumi Chikanori,Yamada Yutaka,Hisano Kyoko,Okuda Sho,Ohtsubo Yoshiki,Iwamoto Chika,Torata Nobuhiro,Mizuuchi Yusuke,Shindo Koji,Nakata Kohei,Moriyama Taiki,Morisaki Takashi,Oda Yoshinao,Nakamura Masafumi

Funder

MEXT | Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s41416-023-02396-7.pdf

Reference59 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

2. Thrift AP. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer. Nat Rev Gastroenterol Hepatol. 2021;18:432–43.

3. Sun J-M, Shen L, Shah MA, Enzinger P, Adenis A, Doi T, et al. Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study. Lancet. 2021;398:759–71.